Ranitidine pharmaceutical compositions
US5456918A · kind A · utility
4Cited by
12References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 13, 1994 |
| Grant date | Oct 10, 1995 |
| Priority date | — |
| Expiry date | Jan 13, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a pharmaceutical composition for use in human or veterinary medicine which comprises ranitidine or a physiologically acceptable salt thereof, alginic acid or a physiologically acceptable salt thereof, and a carbonate or bicarbonate. The composition preferably comprises 1.25% to 10% w/w ranitidine hydrochloride, 5% to 35% w/w alginic acid, and 2% to 15% w/w sodium bicarbonate and is preferably in the form of a capsule or tablet. The compositions are suitable for the treatment of gastrointestinal disorders and particularly reflux oesophagitis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.